Arecor continues collaboration with Lilly

Development of an enhanced formulation of Lilly proprietary product using Arecor’s formulation technology platform Arestat™

Clinical considerations & payer perspectives

Late October saw the annual gathering of oncologists and industry in Madrid for ESMO 2023, bringing with it a wave of new clinical results across cancers and a fresh round of questions concerning pricing, access and reimbursement.

Redundancy: A Golden-Ticket Opportunity

Providing support and strategies for individuals whose roles were made redundant in the Biopharma, Medical Devices, and Health Tech industries

Matrix Bio, a Cambridge based biotech startup wins the o2h tech kickstarter 2.0 competition

Cambridge, UK: We are thrilled to announce the first winner of the tech Kickstarter 2.0 Competition – Matrix Bio! Based in Cambridge, Matrix Bio is an early-stage tech bio startup developing disruptive digital platforms to transform how researchers design and optimize hydrogels.

5 key considerations in connected device development

The value of a well-managed connected device can be significant, to both individuals and businesses.

PlaqueTec recruits first ten patients in BIOPATTERN trial

Cambridge, UK: PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), announces that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.

Are employers responsible for the sick leave of workers they've sponsored?

Immigration lawyer Julie Moktadir says the demands of the health and care sector often sees employers asking questions in respect of sponsored workers.

Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema

Cambridgeshire and Nottingham, UK, 28 November 2023: Exonate Ltd., an mRNA therapy company focused on treatments for diabetic complications, announces its lead ophthalmology asset, EXN407, has achieved its prespecified endpoints in a phase Ib/IIa study.

UK falling behind rest of the world on realising value from new technology - Deloitte

New research from Deloitte reveals the top barriers to implementing and monetising digital technologies such as Cloud, AI and machine learning; Three-quarters of UK organisations believe that digital transformation is the single most important investment they can make; But, 30% of UK organisations lack a transformation strategy, while nearly a third lack understanding of new technology.

Still time for agri and food-tech businesses to apply for innovation grants of up to £300,000

There is still time for businesses in the agri-tech, agri-biotech and food-tech sectors to apply for grants and support to boost innovation and growth.

Strategies for combination therapy in oncology: Part two - Working with the “status quo”

This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe.

Source Genomics White Paper explores the transformative power of multi-omics in genomic research

Multiomics combines the various ‘omics disciplines that make up the complex landscape of life science research. With the integration of genomic, transcriptomic, proteomic and epigenomic data, we obtain an advanced vision of the overarching framework behind all phenotypic outcomes. 

Prologis UK announces letting of prime lab space at Europe’s leading life sciences hub

Prologis UK, a leading property developer, investor and owner, has secured a 15-year lease from Cambridge University Hospitals NHS Foundation Trust (CUHT) for the top floor of its newly developed, state-of-the-art life sciences facility at Cambridge Biomedical Campus (CBC).

Celebrating our Centres - Moorfields

This week, we hear from our colleagues at the NIHR BioResource Centre Moorfields in London about their rare and common eye disorders research. We also celebrate examples of recent progress and find out about the outcomes from a successful patient and public co-development project.

Brilliant impulse alumni continue to dazzle as application window for 2024 programme opens

ALUMNI of University of Cambridge’s hugely successful entrepreneurship and intrapreneurship programme, impulse continue to shine as the application window for the new 2024 intake opens.

CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA

Six-year collaboration recognised at prestigious awards ceremony for its continued success in advancing OOC research to support widespread adoption across the pharmaceutical industry.

OBN (UK) Ltd shines a light on outstanding companies within the life sciences industry, at the 2023 OBN Awards, 22 November 2023, London

Abingdon, UK – OBN (UK) Ltd., the not-for-profit membership organisation that catalyses growth for the life sciences industry, is delighted to announce the winners of their 2023 OBN Awards, presented at the Royal Lancaster, London, on Wednesday 22 November.

Unleashing the potential of Micro 3D Printing with the BMF PµSL System

IPFL is at the forefront of micro 3D printing innovation with the BMF PµSL system, offering unparalleled precision in manufacturing microscale components. Ideal for aerospace, medical, and electronics industries, this advanced technology enables the creation of highly detailed parts previously impossible with traditional methods. The PµSL system excels in rapid prototyping and reducing production…

Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations

Cambridge, UK: Broken String Biosciences, a genomics company that has built a technology platform to drive the development of cell and gene therapies that are safer by design, announces the appointment of Gavin Burns, PhD, as Vice President of Quality and Operations.

CDMO: EUROAPI completes acquisition of Biano

CDMO: EUROAPI completes acquisition of Biano

Paris – November 21, 2023 – EUROAPI today announced the completion of the acquisition of BianoGMP (“Biano”), strengthening its CDMO expertise in the high-growth oligonucleotide market.

Antimicrobial Resistance Policy Solutions

It is difficult to imagine someone who hasn’t called on antibiotics to help them through an infection or protect them during a surgery. Thanks to developments over the last 150 years, once life-threatening bacterial encounters have been relegated to minor inconveniences. Or have they?

Yourgene Health becomes a PacBio Compatible Partner: enabling PacBio customers to optimise size selection for long-read sequencing libraries

Yourgene’s LightBench® instrument offers precise and accurate size selection of PacBio® SMRTbell® sequencing libraries increasing HiFi sequencing yields

First product incorporating Arecor’s Arestat Technology, AT220, launches in Europe

First commercial sale triggers milestone payment and future royalties to Arecor

Cambridge Innovation Capital announces its investment in T-Therapeutics’ £48 Million Series A Funding

Cambridge Innovation Capital (CIC), the venture capital investor focused on deeptech and life sciences businesses in the Cambridge ecosystem, has invested in T-Therapeutics’ £48 Million Series A funding round alongside leading European and US life science investors Sofinnova Partners, F-Prime Capital and Digitalis Ventures, with participation from Sanofi Ventures and the University of Cambridge…

Local psychiatrists publish expert guidance in new books

Experts at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT), Cambridge University and the NIHR Applied Research Collaboration East of England (NIHR ARC EoE) have contributed two new textbooks to the psychiatry canon, which have been published today.